Patient enrollment a strong predictor of phase II oncology trials total expenses
Published October 16, 2013 by OSP
A recent study found phase II trials with 100 or fewer patients cost an average of $4.9 million. Trials with 101 to 199 patients cost an average of $7 million. Finally, the cost of trials with more than 200 patients increases tremendously, to an average of $25.7 million.